NewsBenzingaCodexis Enters Agreement With An Unnamed siRNA Drug Innovator To Explore Stereo-Defined Fragment Synthesis Using Its ECO Synthesis Manufacturing Platform Codexis Enters Agreement With An Unnamed siRNA Drug Innovator To Explore Stereo-Defined Fragment Synthesis Using Its ECO Synthesis Manufacturing Platform Benzinga 2026.09.28 10:03 (GMT+0) Open on Benzinga Other news Important News from Last Night and This Morning (October 19–October 20) Stock Pickers Burned by the AI Boom Think Their Moment Has Finally Arrived Walmart’s Flipkart is quietly building a food delivery challenger in India Robotics AI Company Dream Labs Completes $90 Million Seed Round, Launches Robot Foundation Model API Elysium, an L2 network in the Hyperliquid ecosystem, to launch mainnet on November 9 ARK Invest buys about $8.1 million of CoreWeave stock, sells about $3.56 million of Palantir stock
